Loading…
avatar for Daniel Bollag

Daniel Bollag

Ariad Pharmaceuticals Inc.
Senior Vice President, Regulatory Affairs and Quality
Dr. Bollag has been at ARIAD Pharmaceuticals since 2009 and serves as Senior Vice President of Regulatory Affairs, Pharmacovigilance and Quality. He has overseen the accelerated registration of ICLUSIG indicated for chronic myeloid leukemia and the development of breakthrough-designated brigatinib for ALK+ non-small cell lung cancer. Previously, Dr. Bollag held positions at Genzyme, sanofi, Bristol-Myers Squibb and Merck. Dr. Bollag has a Ph.D. in Biochemistry from Cornell University and degrees in Science and French from the Pennsylvania State University.